Home / Erythromycin / Norway
NO ATC J01FA01 · updated 2 Nov 2026
Erythromycin shortage in Norway
Is there an Erythromycin shortage in Norway?
Yes. As of 2 Nov 2026, 2 Erythromycin products are reported short in Norway, the first since 2 Dec 2024. The company estimate for the return is 31 Oct 2027. Main reason: regulatory or licensing.
Also short in Canada, Germany, Italy, Spain, Ireland, Belgium, Sweden, New Zealand, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Abboticin 100 mg/ml granulat til mikstur, suspensjon, 100 ml flaske | Amdipharm Limited | 2 Dec 2024 | 31 Oct 2027 | Regulatory or licensing Regulatorisk endring |
| NO | Abboticin 250 mg tablett, drasjert, 30 stk boks | Amdipharm Limited | 1 Mar 2026 | 31 Oct 2027 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).